Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loren J Field

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Cardiovascular Research|November 14, 2018
Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicityWuqiang Zhu, Sean Reuter, Loren J Field
Novartis Foundation Symposium|October 6, 2006
The cardiomyocyte cell cyclePascal J E Lafontant, Loren J Field
Journal of the American Society of Nephrology : JASN|April 22, 2004
Allogeneic stem cell-derived "repair unit" therapy and the barriers to clinical deploymentTerry B Strom, Loren J Field, Manfred Ruediger
Circulation|November 16, 2005
Cell-based cardiac repair: reflections at the 10-year pointCharles E Murry, Loren J Field, Philippe Menasché
Biochimica Et Biophysica Acta|November 13, 2012
Challenges measuring cardiomyocyte renewalMark H Soonpaa, Michael Rubart, Loren J Field
Current Opinion in Immunology|August 17, 2002
Allogeneic stem cells, clinical transplantation and the origins of regenerative medicineTerry B Strom, Loren J Field, Manfred Ruediger
Pediatric Cardiology|April 3, 2009
2008 Riley Heart Center Symposium on cardiac development: growth and morphogenesis of the ventricular wallLoren J Field, Weinian Shou, Randall L Caldwell
Cardiovascular Research|May 10, 2014
P53 inhibition exacerbates late-stage anthracycline cardiotoxicityWuqiang Zhu, Wenjun Zhang, Weinian Shou, et al.
Heart Failure Reviews|July 25, 2003
Cell cycle regulation to repair the infarcted myocardiumJoshua D Dowell, Loren J Field, Kishore B S Pasumarthi
Cell Cycle (Georgetown, Tex.)|October 18, 2008
The cullin7 E3 ubiquitin ligase: a novel player in growth controlAntonio Sarikas, Xinsong Xu, Loren J Field, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Cardiovascular Research|November 14, 2018
Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicityWuqiang Zhu, Sean Reuter, Loren J Field
Novartis Foundation Symposium|October 6, 2006
The cardiomyocyte cell cyclePascal J E Lafontant, Loren J Field
Journal of the American Society of Nephrology : JASN|April 22, 2004
Allogeneic stem cell-derived "repair unit" therapy and the barriers to clinical deploymentTerry B Strom, Loren J Field, Manfred Ruediger
Circulation|November 16, 2005
Cell-based cardiac repair: reflections at the 10-year pointCharles E Murry, Loren J Field, Philippe Menasché
Biochimica Et Biophysica Acta|November 13, 2012
Challenges measuring cardiomyocyte renewalMark H Soonpaa, Michael Rubart, Loren J Field
Current Opinion in Immunology|August 17, 2002
Allogeneic stem cells, clinical transplantation and the origins of regenerative medicineTerry B Strom, Loren J Field, Manfred Ruediger
Pediatric Cardiology|April 3, 2009
2008 Riley Heart Center Symposium on cardiac development: growth and morphogenesis of the ventricular wallLoren J Field, Weinian Shou, Randall L Caldwell
Cardiovascular Research|May 10, 2014
P53 inhibition exacerbates late-stage anthracycline cardiotoxicityWuqiang Zhu, Wenjun Zhang, Weinian Shou, et al.
Heart Failure Reviews|July 25, 2003
Cell cycle regulation to repair the infarcted myocardiumJoshua D Dowell, Loren J Field, Kishore B S Pasumarthi
Cell Cycle (Georgetown, Tex.)|October 18, 2008
The cullin7 E3 ubiquitin ligase: a novel player in growth controlAntonio Sarikas, Xinsong Xu, Loren J Field, et al.
Pageof 8